Moderna gains 14% to set fresh 52-week high (MRNA:NASDAQ)
· seekingalpha.com
Moderna (MRNA) jumps 14% to a new 52-week high as cancer vaccine buzz and Nasdaq-100 inclusion lift shares.
SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication.
Moderna (MRNA) shares s...